These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 26401038)

  • 21. Deletion of a major neutralizing epitope of human papillomavirus type 16 virus-like particles.
    Ryding J; Dahlberg L; Wallen-Öhman M; Dillner J
    J Gen Virol; 2007 Mar; 88(Pt 3):792-802. PubMed ID: 17325351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping the B cell epitopes within the major capsid protein L1 of human papillomavirus type 16.
    Wang A; Li N; Zhou J; Chen Y; Jiang M; Qi Y; Liu H; Liu Y; Liu D; Zhao J; Wang Y; Zhang G
    Int J Biol Macromol; 2018 Oct; 118(Pt A):1354-1361. PubMed ID: 29959021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cryoelectron Microscopy Maps of Human Papillomavirus 16 Reveal L2 Densities and Heparin Binding Site.
    Guan J; Bywaters SM; Brendle SA; Ashley RE; Makhov AM; Conway JF; Christensen ND; Hafenstein S
    Structure; 2017 Feb; 25(2):253-263. PubMed ID: 28065506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of Surface-Exposed Loops on the HPV16 Capsid to Antigenic Domains Recognized by Vaccine or Natural Infection Induced Neutralizing Antibodies.
    Godi A; Vaghadia S; Cocuzza C; Miller E; Beddows S
    Microbiol Spectr; 2022 Jun; 10(3):e0077922. PubMed ID: 35475682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Worldwide genetic variations in high-risk human papillomaviruses capsid L1 gene and their impact on vaccine efficiency.
    Oumeslakht L; Ababou M; Badaoui B; Qmichou Z
    Gene; 2021 May; 782():145533. PubMed ID: 33636291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A human monoclonal antibody against HPV16 recognizes an immunodominant and neutralizing epitope partially overlapping with that of H16.V5.
    Xia L; Xian Y; Wang D; Chen Y; Huang X; Bi X; Yu H; Fu Z; Liu X; Li S; An Z; Luo W; Zhao Q; Xia N
    Sci Rep; 2016 Jan; 6():19042. PubMed ID: 26750243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition.
    Day PM; Thompson CD; Buck CB; Pang YY; Lowy DR; Schiller JT
    J Virol; 2007 Aug; 81(16):8784-92. PubMed ID: 17553881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient production of chimeric human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants.
    Matić S; Rinaldi R; Masenga V; Noris E
    BMC Biotechnol; 2011 Nov; 11():106. PubMed ID: 22085463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
    Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epitope clustering analysis for vaccine-induced human antibodies in relationship to a panel of murine monoclonal antibodies against HPV16 viral capsid.
    Zhang C; Huang X; Chen S; Li Y; Li Y; Wang X; Tang J; Xia L; Lin Z; Luo W; Li T; Li S; Zhang J; Xia N; Zhao Q
    Vaccine; 2018 Oct; 36(45):6761-6771. PubMed ID: 30287156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of a human papillomavirus type 16 variant-dependent neutralizing epitope.
    Roden RB; Armstrong A; Haderer P; Christensen ND; Hubbert NL; Lowy DR; Schiller JT; Kirnbauer R
    J Virol; 1997 Aug; 71(8):6247-52. PubMed ID: 9223527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minor Capsid Protein L2 Polytope Induces Broad Protection against Oncogenic and Mucosal Human Papillomaviruses.
    Pouyanfard S; Spagnoli G; Bulli L; Balz K; Yang F; Odenwald C; Seitz H; Mariz FC; Bolchi A; Ottonello S; Müller M
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29212932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphorylation of Human Papillomavirus Type 16 L2 Contributes to Efficient Virus Infectious Entry.
    Broniarczyk J; Massimi P; Pim D; Bergant Marušič M; Myers MP; Garcea RL; Banks L
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
    J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 3.0-Angstrom Resolution Cryo-Electron Microscopy Structure and Antigenic Sites of Coxsackievirus A6-Like Particles.
    Chen J; Zhang C; Zhou Y; Zhang X; Shen C; Ye X; Jiang W; Huang Z; Cong Y
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Humoral immune response recognizes a complex set of epitopes on human papillomavirus type 6 l1 capsomers.
    Orozco JJ; Carter JJ; Koutsky LA; Galloway DA
    J Virol; 2005 Aug; 79(15):9503-14. PubMed ID: 16014913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maturation of the human papillomavirus 16 capsid.
    Cardone G; Moyer AL; Cheng N; Thompson CD; Dvoretzky I; Lowy DR; Schiller JT; Steven AC; Buck CB; Trus BL
    mBio; 2014 Aug; 5(4):e01104-14. PubMed ID: 25096873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arrangement of L2 within the papillomavirus capsid.
    Buck CB; Cheng N; Thompson CD; Lowy DR; Steven AC; Schiller JT; Trus BL
    J Virol; 2008 Jun; 82(11):5190-7. PubMed ID: 18367526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a non-denaturing electrophoresis system for characterization of neutralizing epitopes on HPV virus-like particles.
    Studentsov YY; Burk RD
    J Virol Methods; 2007 Feb; 139(2):208-19. PubMed ID: 17137641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural variants in the major neutralizing epitope of human papillomavirus minor capsid protein L2.
    Seitz H; Schmitt M; Böhmer G; Kopp-Schneider A; Müller M
    Int J Cancer; 2013 Feb; 132(3):E139-48. PubMed ID: 22961598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.